Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours […]
WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development
With an annual dividend yield of 2.5% as of May 29, A. O. Smith Corporation (NYSE:AOS) is included among the
Global Times: Writer Chen Jiming on qiaopi culture, Home Letter, and the shared emotional roots behind hit film Dear You’s
It’s a sad reality that the UK State Pension alone will not provide for a comfortable retirement. That’s why millions
We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot. Magnite Inc (NASDAQ:MGNI) ranks
I have over 20 companies in my Stocks and Shares ISA today, but a couple of them might be gone
Investing.com — Bitcoin edged higher on Saturday after tumbling to a seven-week low near $72,000 in the previous session, weighed
Promising Data Further Support Continued Expansion of Ivonescimab Clinical Development in mCRC Overall Study Population Achieved ORR of 70.8% and
We just covered the From Fired Researcher to $13.7 Billion King: How Leopold Aschenbrenner Broke the Hedge Fund World and
